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Membrane microﬁltrationAbstract In the present study green chemistry was employed for synthesizing ZnO nanoparticles
using the extract of black tea solid waste and Zn acetate dihydrate. The characterization of the
green synthesized ZnO was conducted by XRD, SEM, HR-TEM, DLS and EDAX. Urine samples
from donors under medication with Ibuprofen, Ephedrine and Propranolol were separated and
collected through a diversion toilet. A batch experiment was conducted in order to determine the
optimum dose of green synthesized ZnO nanoparticles for the removal of the pharmaceutical com-
pounds from human urine. The determined optimum dose of the ZnO nanoparticles was 1.5 g/l.
ZnO nanoparticle possess the ability to adsorb the Pharmaceutical active compounds (PACs) on
the surface. In addition, it binds such adsorbed particles and facilitates their precipitation.
Coagulant reagents react with some of the suspended and colloidal particles in water/
wastewater to enhance their binding together, thus, allowing their removal in the subsequent treat-
ment processes. The mechanism of aggregation consists of the combination of charge neutraliza-
tion, entrapment, adsorption and/or complexion with the coagulant ions to form insoluble
precipitate. Thus, the particles and colloids can be removed. A semi-pilot plant consisted of mixing
tank for chemical coagulation using the predetermined ZnO nanoparticles followed by microﬁltra-
tion unit, was designed and operated continuously for the treatment of the separated urine. The
overall results of the semi-pilot study showed that the concentration of Ibuprofen, Ephedrine
and Propranolol decreased from 5.0, 10.15 and 15.2 mg/l to 0.01, 0.10 and 0.03 mg/l respectively.ed ZnO-
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nanoparticles followed by microfiltration forThe overall removal rate exceeded 99%. Meanwhile, the treatment system succeeded to improve the
physical and chemical characteristics of the contaminated human urine. The treated urine could be
safely used for agriculture purposes without any environmental threat.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pharmaceutical active compounds (PACs) have, presently, been classi-
ﬁed as emerging pollutants of concern because of their detection in
aquatic environment and surface waters. High consumption of PACs
of more than $250 billion (Khetan and Collins, 2007) in the USA
during 2006, provides a continuous input of the PACs into the
environment. Such PACs can enter wastewater treatment plants via
excretion (Kummerer, 2004), industrial facilities (Larsson et al.,
2007), or even disposal of unused or expired drugs (Abdel-Shafy and
Mansour, 2013a). The removal efﬁciency of the PACs in treatment
plants varies widely, often ended by their discharge into receiving
streams and natural bodies of water (Beausse, 2004; Martyn et al.,
2011; Camacho-Mu¸noz et al., 2010; Abdel-Shafy and Mansour,
2013b).
These PACs can end up onto soils when sewage sludge is employed
as fertilizer (Beausse, 2004; Camacho-Mu¸noz et al., 2010). Their occur-
rence in surface water has been documented by several investigators
(Ashton et al., 2004; Fatta-Kassinos et al., 2011; Spongberg et al.,
2011; Abdel-Shafy and Mansour, 2013c). The most important source
of pharmaceuticals in the environment and water cycle is via human
metabolism. These compounds are partially metabolized by the human
body. Therefore, they enter the environment either as parent com-
pounds (unchanged), or as a mixture of metabolites and/or conjugated
compounds (Jjemba, 2006; Lienert et al., 2007). Generally, PACs are
excreted largely through urine (generally 55–80% of the total with
an average of 70%, with few exceptions) and partially in the feces
(Abdel-Shafy and Mansour, 2013a).
In the 1990s and beyond, various researchers worked on the same
concept by separating urine at source for the purpose of promoting the
sustainability of wastewater management (Larsen and Gujer, 1996;
Regelsberger et al., 2007; Masi et al., 2010). All these researches are
based on the fact that urine contains most of chemical nutrient ele-
ments in domestic wastewater. However, it makes up less than 1%
of the total wastewater volume. Adequate separation of urine at source
would, therefore, allow nutrient recycling. Meanwhile, it would mini-
mize advanced nutrient removal, including nitriﬁcation, denitriﬁcation
and phosphorus elimination (Wilsenach and Van Loosdrecht, 2004).
Separation of urine presents several advantages. Besides the above
mentioned advantages, it offers better ways of removing organic
micro-pollutants resulted from the human metabolism (Wilsenach
and Van Loosdrecht, 2004; Abdel-Shafy and Mansour, 2013b). This
leads to more efﬁcient wastewater management (Larsen and Gujer,
2001).
Recently, several investigators studied the elimination of PACs
from contaminated urine using Fenton’s reagents. The overall conclu-
sion is that Fenton’s treatment can be rated as uneconomical method
for larger volumes of urine (Abdel-Shafy and Mansour, 2013b). How-
ever, this Fenton’s oxidation is considered an effective pre-treatment
method for the non-biodegradable portions, which could render them
to be ready for biodegradation by the following biological processes. If
the Fenton’s oxidation is employed as a pre-treatment method, lower
dose of such reagents can be used. Thus, puriﬁed urine can be used
safely for agricultural purpose without any hazard of pharmaceutical
contamination (Abdel-Shafy and Mansour, 2013a).
On the other hand, membrane technology proved to be effective for
the separation of pharmaceutical compounds from urine (Abdel-Shafy
and Mansour, 2016; Abdel-Shafy and Mohamed-Mansour, 2014).
Nanoﬁltration was employed for pharmaceutical and estrogenic.S.M. et al., Removal of pharmaceutic
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that can be used as fertilizer (Pronk et al., 2006; Abdel-Shafy, Al-
Sulaiman, et al., 2015; Abdel-Shafy, Schories, et al., 2015).
Meanwhile, chemical coagulation and ﬂocculation for water/
wastewater treatment proved to be efﬁcient for altering some of the
dissolved and suspended matters into precipitate. Thus, it facilitates
their removal by sedimentation (Matilainen et al., 2010;
Abdel-Shafy, 2015; Abdel-Shafy and Al-Sulaiman, 2014). Coagulant
reagents react with some of the suspended and colloidal particles in
water/wastewater to enhance binding them together, thus, allowing
their removal in the subsequent treatment processes (Lia et al.,
2006). The mechanism of aggregation consists of the combination of
charge neutralization, entrapment, adsorption and/or complexion with
the coagulant ions to form insoluble precipitate. Thus, the particles
and colloids can be removed (Matilainen et al., 2010; Verma et al.,
2012). Coagulation process forms an integral part of the conventional
water/wastewater treatment and has been employed to decrease
turbidity, color and to remove pathogens (Matilainen et al., 2010;
Verma et al., 2012).
On the other hand, nanoparticles possess the unique size property.
Such property depends on what is known as high ‘aspect ratio’, which
is the ratio between the surface areas to the volume. The smaller the
particle size the greater will be the aspect ratio (i.e., greater surface area
compared to their volume). Thus, the higher ‘aspect ratio’ enhances the
reactivity of the nanoparticles with the surrounding molecules.
Synthesizing the nanoparticles by conventional methods has some
adverse effects (i.e. the critical conditions of temperature and pressure
cost of chemicals, long reﬂuxing time of reaction, toxicity of the
byproducts, etc.). Chemical synthesis of ZnO is reported by several
investigators (Omri et al., 2014). On the contrary, synthesizing the
nanoparticles via green methods has gained recently signiﬁcant
importance and it became one of the most adequate and preferred
methods. The advantages of green synthesis procedures include simple,
good stability of the nanoparticles, inexpensive, non-toxic byproducts,
less time consuming and large-scale synthesis (Awad et al., 2013;
Moritz and Geszka-Moritz, 2013; Hassan et al., 2015).
More recently, several studies have been reported on the synthe-
sizing of green nanoparticles of the noble metals including silver
(Ag) and gold (Au) in terms of their antimicrobial activities (Awad
et al., 2013). Meanwhile, few studies were carried out on the green
synthesis of some metal oxide nanoparticles including AlO, CuO,
FeO2, MgO, TiO2 and ZnO (Awad et al., 2013; Moritz and
Geszka-Moritz, 2013). Further extensive work has been done to
study the plant assisted reduction of metal nanoparticles along with
the respective role of phytochemicals. The most important water
soluble phytochemicals are ﬂavones, quinones and organic acids.
They are responsible for the immediate reduction. In addition,
protocatechualdehyde and catechol were reported in the hydrophyte
studies together with other phytochemicals. It was conﬁrmed that
catechol in the alkaline conditions is transformed into protocate-
chaldehyde then into protocatechuic acid in the ﬁnal stage. These
two processes liberated hydrogen. It was reported by Jha and
Prasad (2009) that these processes play role in the synthesis of the
nanoparticles. It is worth mentioning that the main phytochemicals
present in the leaves of black tea consist of water soluble Catechins,
Theaﬂavins and Thearubigins. They are oligomers of catechins of
unknown structure. It was, therefore, suggested that water soluble
phytochemicals of tea may be able to play a major role in the overall
reduction reactions (Larsen and Gujer, 1996).al compounds from urine via chemical coagulation by green synthesized ZnO-
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
Figure 1 Urine diversion toilet.
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the pharmaceutical active compounds (PACs) from urine for safe reuse.
The purpose of this study was to remove the pharmaceutical contami-
nants from urine. Therefore the puriﬁed urine can be used for agriculture
purpose as environmental friendly source of nutrient elements. The
investigation includes two successive steps. The ﬁrst step is to examine
green synthesized ZnO nanoparticles and to examine the efﬁciency of this
ZnO for the elimination of PACs. The second step is to investigate the
efﬁciency of microﬁltration for the removal of the pharmaceutical com-
pounds from urine. The ZnO nanoparticles were synthesized by a green
chemistry method. The present investigation was examined by both
bench laboratory scale and semi-pilot continuous systems.
2. Materials and methods
2.1. Chemicals
Zinc acetate dihydrate (99% purity) and sodium hydroxide
(pellet, purity 99%) were purchased from Sigma–Aldrich (St.
Louis, MO). Ibuprofen (purity 99%), Ephedrine (purity
99%) and Propranolol (purityP 99%) standards were also
purchased from Sigma–Aldrich (St. Louis, MO).
2.2. Synthesization and characterization of zinc oxide
nanoparticles
2.2.1. Preparation of the extract
The extract was prepared by weighing 2.0 g of dried black tea
solid waste, this amount was placed in 200 ml glass beaker and
100 ml of deionizer water was added. The mixture was placed
on a hot plate and was heated gently until boiling. The gentle
boiling was continued until the color of the aqueous solution
changes to dark red. The extract was cooled to room temper-
ature and ﬁltered using Whatman (No. 40) ﬁlter paper. A qual-
itative analysis of the black tea solid waste extract was carried
out according to Trease and Evans, (1989)
2.2.2. Green synthesization of ZnO nanoparticles
A weight of 0.2 g zinc acetate dihydrate was added to 50 ml of
distilled water. The mixture was stirred vigorously for 10 min.
A volume of 1.0 ml of the black tea extract was added to the
Zn acetate solution. NaOH (2.0 M) was added dropwise until
the pH increased to 12. At this moment a pale white aqueous
solution was gained. The mixture was stirred slowly to allow
the precipitation of ZnO nanoparticles. The obtained pale white
precipitate was collected and washed several times with double
distilled water, followed by ethanol. The centrifuge was employed
for collecting the ZnO nanoparticles after each step of washing.
The collected powder was dried at 70 C for overnight period.
2.2.3. Characterization of green synthesized ZnO nanoparticles
The pale white powder of ZnO nanoparticles was carefully col-
lected and characterized using XRD, SEM, HR-TEM, DLS
and EDAX before conducting any experimental investigation.
Furthermore, the antibacterial activity of green synthesized
ZnO nanoparticles was also examined according to Moritz
and Geszka-Moritz, (2013).
2.3. Raw urine sources
Urine diversion toilet was installed at the semi-pilot plant in
the National Research Center (NRC), Cairo, Egypt (Fig. 1).Please cite this article in press as: Hassan, S.S.M. et al., Removal of pharmaceutica
nanoparticles followed by microfiltration for safe reuse. Arabian Journal of ChemisThrough piping system, the separated urine was directed to
the semi-pilot plant and ﬁnally to a collection tank in the
NRC. The toilet users were under medication with Ibuprofen,
Ephedrine and Propranolol.
2.4. Laboratory batch experiment
Jar test was employed to determine the optimum dose of green
synthesized ZnO nanoparticles for the removal of pharmaceu-
tical active compounds from the collected contaminated urine.
Different doses of ZnO nanoparticles (namely: 0.5, 0.7, 1.0,
1.3, 1.5 and 1.7 g/l) were examined. The addition of the green
ZnO nanoparticles was under ﬂash mixing for 5 min at
350 rpm, followed by ﬂocculation for 30 min at 80 rpm and
ﬁnally sedimentation for 60 min.
2.5. Semi-pilot plant
A semi-pilot plant as continuous system was designed for the
treatment of the contaminated urine (Fig. 2). This semi-pilot
plant consists of collection, coagulation/ﬂocculation and
sedimentation tanks followed by membrane microﬁltration sys-
tem (Fig. 2). The study was carried out at room temperature.
2.5.1. Coagulation, flocculation and sedimentation tanks
Two bafﬂed tanks were used. The ﬁrst bafﬂed tank with an
effective dimension of 0.4 m  0.4 m  0.8 m was used for
chemical coagulation/ﬂocculation. The second bafﬂed tank
was used for sedimentation with an effective dimension of
0.5 m  0.5 m  0.5 m. The predetermined optimum dose of
green synthesized ZnO nanoparticles was added to the
coagulation tank along with the urine pathway using dosing
pump. Both liquids namely the contaminated urine and the
ZnO solution were mixed together before reaching the tank
by passing them together through circled tube to allow a
complete mixing. The liquid was then slowly ﬂown to allow
the formation of the ﬂocks. Finally the efﬂuent was ﬂown grad-
ually to the sedimentation tank for settling all the particles.l compounds from urine via chemical coagulation by green synthesized ZnO-
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
Figure 2 Schematic diagram of the treatment system (where UDT, C.T., CCFT, ST and MF are the urine diversion toilet, the collection
tank, the chemical coagulation/ﬂocculation tank, the settling tank and microﬁltration unit respectively).
Table 1 speciﬁcation of pilot MF-membrane unit.
Item Speciﬁcationa
The material of the
membrane
Polyelectrolyte complex (PEC)
Surface area of the
Membrane
0.6 m2




Resistance/pH range between 1.5 and 10




Max. 1–3 (1.02 mWS¼ 10 kPa)
a As given by the manufacturer.
4 S.S.M. Hassan et al.2.5.2. Membrane microfiltration laboratory scale unit
The efﬂuent of the sedimentation tank was directed by a
dosing pump to the membrane microﬁltration (MF) system
for further treatment (Fig. 2). The feeding to the membrane
system was from the top of the MF unit.
The MF membrane unit was especially designed in 2014 as
a treatment system for water and wastewater. The microﬁltra-
tion pore size was 0.378 lm to guarantee and provide reliable
separation of bacteria and all particulate matters. Up-ﬂow
aeration from the bottom of the MF reactor was supplied by
a compressor of 116 psi (pounds per square inch) pressure
capacity. The aeration was daily supplied to facilitate aerobic
environment of the system as well as minimizing any possible
fouling or clogging of the membrane reactor. In addition, foul-
ing on the surface of the plate and frame module (KUBOTA)
is controlled through tangential ﬂow along the MF membrane
surface. In order to avoid any fouling problem, the backwash-
ing of the membrane was carried out monthly during the
entire experimental work (Judd, 2004). The necessary trans-
membrane pressure difference is applied by the water head
(1.4 m height) above the membrane to allow the gravity ﬂow.
Thus the system was operated without any energy input
(Strathmann et al., 2006; Abdel-Shafy, Al-Sulaiman, et al.,
2015; Abdel-Shafy, Schories, et al., 2015). In this respect, the
aeration system of MF-membrane could save about 40% of
the total required energy (i.e. the energy consumption was
about 60% of the total required energy). A rough estimation
of the present study reveals that applying the water head
(1.1 m height) for gravity ﬂow of wastewater could save
between 30% and 40% of the total required energy. The small
pore sizes of the MF-membrane guarantee retaining any
possible nitrifying bacteria and other microorganisms in the
reactor. Furthermore, the separation by MF-membranes was
able to allow mixed liquor suspended solid concentrations that
by far exceed the usual 2–4 g/L in conventional treatment sys-
tems. The main purpose was to obtain an efﬂuent free of any
germs and particles. The experiments were carried out in the
MF-reactor that was operated under aerobic conditions
(oxygen concentration in the tank ranged between 1 and 4
mgO2/L). Meanwhile, the continuous aeration provided for
MF limited membrane fouling and could successfully maintain
the aerobic condition of the reactor. The speciﬁcations of the
pilot MF-membrane unit are given in Table 1.Please cite this article in press as: Hassan, S.S.M. et al., Removal of pharmaceutic
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system
The ZnO treated efﬂuent was pumped from the sedimentation
tank to the top of the MF reactor (Fig. 2). The urine ﬂew in the
aerobic MF by gravity. The ﬁnal efﬂuent was reused for agri-
culture purposes. The schematic diagram of the treatment sys-
tem is shown in Fig. 2.
2.6. Analytical measurement
XRD [PANalytical-Empyrean] was used in order to investigate
the purity of synthesized ZnO nanoparticles under the follow-
ing condition: Scan Axis: Gonio, Start Position [2Th.]: 5.0129,
End Position [2Th.]: 79.9709, Step Size [2Th.]: 0.0260, Scan
Step Time [s]: 18.8700, Scan Type: Continuous, PSD Length
[2Th.]: 3.35, Measurement Temperature [C]: 25.00, Anode
Material: Cu, K-Alpha1 [A˚]: 1.54060, K-Alpha2 [A˚]:
1.54443, K-Beta [A˚]: 1.39225, K-A2/K-A1 Ratio: 0.50000,
Generator Settings: 30 mA, 45 kV.
SEM [quanta FEG 250] gives illustration on the surface
morphology of synthesized ZnO nanoparticles. HR-TEM
[JEOL JEM – 2100 electron microscope] was used to gain
the actual particle size of synthesized ZnO nanoparticles.
EDAX [AMETEK material analysis device] was also used
for ZnO nanoparticles characterization. DLS [Malvernal compounds from urine via chemical coagulation by green synthesized ZnO-
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
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the source of the laser that is He-Ne was used for zeta potential
measurement.
The concentration of pharmaceutical active compounds in
the raw contaminated urine as well as through all the study
periods was determined using Water 2795 HPLC equipped
with Quattro Ultima MS/MS detector and a column: water
X Terra C18, 3.5 lm, 10 cm, 2.1 mm. Ionization: Electro-
spray positive (ES+). Acquisition: MRM mode, unit resolu-
tion. The mobile phase consisted of (A) 0.3% formic acid
and 0.1% Ammonium format, and (B) 1:1 acetonitrile:metha-
nol. The solvent program was Gradient; the injection volume
was 5 lL.
The physical and chemical characteristics of the studied
urine including COD (total and dissolved), BOD, nitrates,
nitrites, ammonia, total phosphates, K, Na and Ca were deter-
mined according to the Standard Methods for Examination of
Water and Wastewater (APHA, 2005).
3. Results and discussions
3.1. Qualitative analysis of the extract
Results of the qualitative analysis of the black-tea solid waste
extract showed that the phytochemical compounds are ﬂavo-
noid, catechin and theaﬂavins. The phytochemical constituents
of black-tea solid waste are responsible for the reduction
activity in the reaction.
3.2. Characterization of green synthesized ZnO nanoparticles
The use of black-tea solid waste extract leads to the reduction
of Zn acetate dihydrate to pure ZnO nanoparticles directly at
pH 12 without any need to calcination. The green synthesized
ZnO nanoparticles were characterized as follows.
The formation of ZnO was conﬁrmed by using XRD. Fig. 3
is the XRD spectra of the synthesized ZnO nanoparticles. The
obtained diffraction peak positions were 31.731, 34.371,
36.219, 47.49, 56.539, 62.79, 64.879, 66.272, 67.87 and
69.09. These data conﬁrm that there are no impurities in the
synthesized ZnO nanoparticles. It also conﬁrms hexagonal
phase of ZnO (Singh et al., 2011). The hexagonal structure
has a point group 6 mm (Hermann–Mauguin notation) or
C6v (Schoenﬂies notation), and the space group is P63mc or
C6v4. The lattice constants are a= 3.25 A˚ and c= 5.2 A˚;
their ratio c/a  1.60 is close to the ideal value for hexagonal
cell c/a= 1.633. As in most group II–VI materials, the bond-
ing in ZnO is largely ionic (Zn2+O2). These properties are
responsible for the preferential formation of wurtzite rather
than zinc blended structure including the strong piezoelectric-
ity property of ZnO. Due to the polar Zn–O bonds, oxygen
and zinc planes are electrically charged. The surfaces of ZnO
are stable, atomically ﬂat and exhibit no reconstruction
(Baruah and Dutta, 2016).
Fig. 4 represents the EDAXS pattern of green synthesized
ZnO nanoparticles. This EDAXS elemental analysis shows
that only Zn and O atoms exist at the atomic ratio of 44%
O:56% Zn.
The surface morphology of green synthesized ZnO
nanoparticles was gained using SEM (Fig 5). It presents thePlease cite this article in press as: Hassan, S.S.M. et al., Removal of pharmaceutica
nanoparticles followed by microfiltration for safe reuse. Arabian Journal of ChemisSEM image of the synthesized ZnO nanoparticles at different
magniﬁcation. It is worth mentioning that this image shows
rod shape of the nanoparticles.
Furthermore, HR-TEM gives the actual particle size. In
addition, Fig. 6 shows HR-TEM image of the green synthe-
sized ZnO nanoparticles, as the average particle size is
19.5 nm.
On the other hand, DLS instrument was employed to mea-
sure the Zeta potential of the green synthesized ZnO nanopar-
ticles. In this respect, Zeta potential is the electric potential in
the interfacial double layer (DL) at the location of the slipping
plane versus a point in the bulk ﬂuid away from the interface.
It is, therefore, the potential difference between the dispersion
medium and the stationary layer of ﬂuid that is attached to the
dispersed particle. The positive or negative value of 25 mV can
be taken as the arbitrary value that separates low-charged
surfaces from highly-charged surfaces. The signiﬁcance of zeta
potential, in the liquid, is that its value can be related to the
stability of colloidal dispersions. Therefore, zeta potential indi-
cates the degree of repulsion between adjacent, similarly
charged particles in dispersion. In case of the molecules and
particles that are small enough, the high zeta potential will
confer stability. In other words, the solution or dispersion will
resist aggregation. When the potential is low, the attraction
exceeds the repulsion; thus, the dispersion will break and
ﬂocculate. Zeta potential (i.e. Surface potential) has a direct
relation with the stability of a form and/or structure. The
obtained zeta potential (Fig. 7) of green synthesized ZnO
nanoparticles was (41.3) mV which indicates a good stability.
DLS is employed to study stability of the particles. In addi-
tion, it shows whether the particles aggregate over time by
observing whether the hydrodynamic radius of the particle
increases. When the particles aggregate, there will be a larger
population of these particles with a larger radius. DLS size
distribution by number: Fig. 8 indicates that the particles are
mono-dispersed. This means that one size range of particles
was formed (i.e. the population of the particle size within the
range of 54 nm was the most population ones).
The role of black tea waste extract on the synthesis of ZnO
Nanoparticles can be explained as follows: Biosynthesis of the
present nanoparticles is considered a type of bottom up
approach in which the main occurring reaction is reduction/
oxidation. In this respect, the microbial enzymes and/or the
plant phytochemical with antioxidant or reducing properties
are generally responsible for the reduction of the metal com-
pounds into their corresponding nanoparticles. The three main
steps for the preparation of nanoparticles that should be eval-
uated from a green chemistry perspective are as follows: (a) the
choice of the solvent medium used for the synthesizing, (b)
the choice of an environmentally benign reducing agent and
(c) the choice of a non-toxic material for the stabilization
of the nanoparticles (Raveendran et al., 2003). In green
nanoparticle synthesis, water is commonly used as an
environmentally benign solvent (i.e. water here replaces the
toxic organic solvents). Recently, biological entities have been
reported to serve as both surface stabilizing and reducing
agents for green synthesis of metallic nanoparticles. The
advantage of using natural plants or their solid waste for the
synthesis of nanoparticles is that they are inexpensive, avail-
able, can be handled safely and possess a broad variability of
metabolites which is effective in reduction.l compounds from urine via chemical coagulation by green synthesized ZnO-
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
Figure 3 X-ray spectra of green synthesized ZnO nanoparticles.
Figure 4 EDAX of green synthesized ZnO nanoparticles.
6 S.S.M. Hassan et al.3.3. Characterization of raw urine sample
Table 2 represents the main characteristics of raw urine in
terms of pH, turbidity, CODT, CODD, BOD, T.P., NO3,
NO2, NH3 K, Na, Ca, Mg and the concentrations of the
pharmaceutical active compounds (namely, Ibuprofen,
Ephedrine and Propranolol). The given results indicate thatPlease cite this article in press as: Hassan, S.S.M. et al., Removal of pharmaceutic
nanoparticles followed by microfiltration for safe reuse. Arabian Journal of Chemisthe urine was collected from patients who were under medica-
tion with the Ibuprofen, Ephedrine and Propranolol.
3.4. Jar-Test batch experiments
The results (Table 3) showed that increasing the dose of ZnO
nanoparticles increases the removal rate of the examinedal compounds from urine via chemical coagulation by green synthesized ZnO-
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
Figure 5 SEM image of green synthesized ZnO nanoparticles at
different magniﬁcation.
Figure 6 HR-TEM image of ZnO nanoparticles synthesized by
using black tea solid waste.
Figure 7 DLS Zeta potential distribution of green synthesized
ZnO nanoparticles.
Figure 8 DLS size distribution by number of green synthesized
ZnO nanoparticles.
Removal of pharmaceutical compounds from urine 7parameters. However, increasing the ZnO dose up to 1.7 g/l
did not exhibit remarkable removal percentage. The optimum
dose of the ZnO nanoparticles was found to be 1.5 g/l at which
the concentration of Ibuprofen, Ephedrine and Propranolol
decreased from 5.00, 10.15 and 15.20 to 0.08, 0.90 and 0.20
respectively (Table 3).
Coagulation and ﬂocculation process for the removal of
pharmaceutical compounds depends mostly on the compounds
propensity to be sorbet on the surface of ZnO nanoparticles.
As a result, hydrophobic compounds with high octanol–water
partition coefﬁcient (logKow) can potentially be removed by
coagulation/ﬂocculation (Lia et al., 2006; Matilainen et al.,
2010; Verma et al., 2012). The high removal of Ibuprofen,
Ephedrine and Propranolol by chemical ZnO coagulation, in
the present investigation, is due to the octanol–water partition
coefﬁcient (logKow) which is equal to 3.97, 1.65 and 3.48 of
Ibuprofen, Ephedrine and Propranolol respectively at 20 C.
The sorption of micro-pollutants including: pharmaceuti-
cals, personal care products (PPCPs) and endocrine (EDCs)
by solids, depends mainly on their physical/chemical proper-
ties, such as lipophilicity or acidity. Meanwhile, the sorption
of these micro-pollutants depends also on their behavior
during the physical/chemical treatment (such as ﬂocculation
and/or adsorption). There are two types of coefﬁcients
namely: (Ko: organic carbon partition coefﬁcient) and (Kow:
octanol–water partition coefﬁcient). Usually, they are used toPlease cite this article in press as: Hassan, S.S.M. et al., Removal of pharmaceutical compounds from urine via chemical coagulation by green synthesized ZnO-
nanoparticles followed by microfiltration for safe reuse. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
Table 2 characteristics of the separated and collected real raw contaminated urine.
Parameter Unit N Minimum Maximum Average
pH . . . 6 4.5 5.3 5.1 ± 0.22
Turbidity NTU 6 190 250 201 ± 0.19
CODT mg l
1 6 19,700 19,950 19,820 ± 86
CODD mg l
1 6 11,800 11,200 11,892 ± 73
BOD5 mg l
1 6 2450 2600 2552 ± 63
BOD5/COD . . . 6 0.09 0.15 0.13
T.P. mg l1 6 180 260 200 ± 31
NO3 mg l
1 6 5 15 10 ± 0.27
NO2 mg l
1 6 34.9 49.8 44.7 ± 0.81
NH3 mg l
1 6 364.2 523.5 491.2 ± 0.56
K mg l1 6 800 900 866 ± 92
Na mg l1 6 500 600 556 ± 78
Ca mg l1 6 1300 1400 1344 ± 69
Mg mg l1 6 40 70 53.5 ± 11
SAR . . . 6 3. 5 6 4.1
Ibuprofen (mg/l) mg l1 6 4.2 5.5 5 ± 0.46
Ephedrine (mg/l) mg l1 6 8 11 10.15 ± 0.69
Propranolol (mg/l) mg l1 6 11 18 15.2 ± 0.89
N* = Number of samples, CODT = Total Chemical Oxygen Demand, CODD=Dissolved Chemical Oxygen Demand, BOD5 = Biological
Oxygen Demands, T.P. = Total Phosphates, NO3 = Nitrates, NO2 = Nitrites, NH3 = ammonia, K = Potassium, Na = Sodium,
Ca = calcium, Mg =Magnesium.
Table 3 Effect of different ZnO nanoparticles doses on the treatment of the raw contaminated urine in a batch experiment.
Parameter N Raw contaminated human urine ZnO nanoparticles dose (g/l)
0.5 0.7 1 1.3 1.5 1.7
pH 7 5.1(±0.22) 7.6 7.8 8.0 8.2 8.6 8.8
Turbidity (NTU) 7 201(±0.15) 47 41 37 36 35 34
CODT (mg/l) 7 19,820(±86) 6400 6080 1200 680 500 489
CODD (mg/l) 7 11,892(±73) 4032 3769.6 732 421.6 310 299
BOD5 (mg/l) 7 2552(±66) 1243.3 974.6 471.6 207.9 100.8 89.9
BOD5/COD 7 0.13 0.19 0.16 0.39 0.31 0.20 0.18
T.P (mg/l) 7 200(±45) 106 96.4 94.4 91.8 91.6 88.3
NO3 (mg/l) 7 10(±0.26) 6.96 5.0 4.7 4.55 4.2 4.0
NO2 (mg/l) 7 44.7(±0.52) 31.7 22.9 20.9 20.3 19.0 17.9
NH3 (mg/l) 7 491.2(±21) 343.0 245.8 228.8 213.5 203.2 197.6
K (mg/l) 7 866(±30) 356 340 320 296 206 199
Na (mg/l) 7 556(±48) 238 198 76 46 25 21
Ca (mg/l) 7 1344(±39) 600 454 292 264 220 209
Mg (mg/l) 7 53.5(±11) 30.1 19.4 15.4 10.1 6.2 5.9
SAR 4.1 2.6 2.4 1.2 0.7 0.45 0.41
Ibuprofen (mg/l) 7 5.0 (±0.88) 3.5 2 1.2 0.9 0.08 0.08
Ephedrine (mg/l) 7 10.15 (±0.95) 5.2 3.2 2 1.4 0.90 0.88
Propranolol (mg/l) 7 15.2 (±0.82) 9.6 6.3 4 1.3 0.20 0.18
N* = Number of samples, CODT = Total Chemical Oxygen Demand, CODD=Dissolved Chemical Oxygen Demand, BOD5 = Biological
Oxygen Demands, T.P. = Total Phosphates, NO3 = Nitrates, NO2 = Nitrites, NH3 = ammonia, K = Potassium, Na = Sodium,
Ca = calcium, Mg =Magnesium.
8 S.S.M. Hassan et al.determine the sorption effectiveness as well as the afﬁnity of a
given compound or substance to efﬂuent organic matter
(EfOM). In this respect, the physical/chemical properties of
the EDCs/PPCPs can be partitioned into three main groups
namely: neutral (nonionic), lipophilic (with high Kow values)
and acidic (hydrophilic and ionic) compounds (carballa
et al., 2005).
By adding the optimum dose of ZnO remarkable removal
of the pollution parameters was observed (Table 2). The con-
centration of CODT, CODD and BOD decreased from
19,820 to 500 mg/l, 11,892 to 310 mg/l and from 2552 toPlease cite this article in press as: Hassan, S.S.M. et al., Removal of pharmaceutic
nanoparticles followed by microfiltration for safe reuse. Arabian Journal of Chemis100.8 mg/l respectively (Table 2). Meanwhile, T.P., NO3,
NO2, NH3, K, Na, Ca, and Mg decreased from 200, 10,
44.7, 491.2, 866, 556, 1344 and 53.5 mg/l to 91.6, 4.2, 19.0,
203.2, 206, 25, 220 and 6.2 mg/l successively. Turbidity also
decreased from 201 NTU and 4.1 NTU.
3.5. Semi-pilot plant continuous system
In the continuous semi-pilot plant (Fig. 2) the predetermined
optimum dose of ZnO nanoparticles namely 1.5 g/l, was added
to the coagulation tank. The obtained results Table 3 indicatedal compounds from urine via chemical coagulation by green synthesized ZnO-
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
Table 4 Characteristics of the raw contaminated urine after treatment in the semi-pilot plant using chemical coagulation by ZO
nanoparticle followed by membrane micro-ﬁltration.
Parameter N Raw contaminated human urine Eﬄuent of ZnO treatment Eﬄuent of microﬁltration Total % Removal
Conc. % Removal Conc. % Removal
pH 9 5.1(±0.22) 8.4 – 8.7 – –
Turbidity (NTU) 9 201(±0.15) 37 81.6 0.6 98.4 99.7
CODT (mg/l) 9 19,820(±86) 500 97.4 79.5 85 99.5
CODD (mg/l) 9 11,892(±73) 340 97.1 68.0 80 99.3
BOD5 (mg/l) 9 2552(±66) 110 95 19.8 82 99.2
BOD5/COD 9 0.13 0.61 0.25 –
T.P (mg/l) 9 200(±45) 92.8 53.6 80.2 13.6 59.9
NO3 (mg/l) 9 10(±0.26) 4.9 51.0 0.6 87.7 94
NO2 (mg/l) 9 44.7(±0.52) 20.8 53.5 1.06 94.9 97.6
NH3 (mg/l) 9 491.2(±21) 144.1 70.7 2.8 98.1 99.4
K (mg/l) 9 866(±30) 215 75 26 87.9 91.3
Na (mg/l) 9 556(±48) 28 94.9 3.6 87.1 99.3
Ca (mg/l) 9 1344(±39) 230 82.8 8.0 96.5 99.4
Mg (mg/l) 9 53.5(±11) 7 86.9 0.7 90 98.7
SAR 4.1 0.6 0.3 –
Ibuprofen (mg/l) 9 5.0 (±0.88) 0.20 96 0.01 95 99.8
Ephedrine (mg/l) 9 10.15 (±0.95) 1.10 89.2 0.10 90.9 99
Propranolol (mg/l) 9 15.2 (±0.82) 0.40 97.4 0.03 92.5 99.8
N* = Number of samples, CODT = Total Chemical Oxygen Demand, CODD=Dissolved Chemical Oxygen Demand, BOD5 = Biological
Oxygen Demands, T.P. = Total Phosphates, NO3 = Nitrates, NO2 = Nitrites, NH3 = ammonia, K = Potassium, Na = Sodium,
Ca = calcium, Mg =Magnesium.
Removal of pharmaceutical compounds from urine 9that the concentration of Ibuprofen, Ephedrine and Propra-
nolol decreased from 5.0, 10.15 and 15.2 mg/l to 0.2, 1.1 and
0.4 mg/l respectively. The concentration of COD and BOD
decreased from 19,820 to 500 mg/l and from 2552 to 110 suc-
cessively. In addition, T.P., NO3, NO2, NH3, K, Na, Ca and
Mg decreased from 200, 10, 44.7, 491.2, 866, 556, 1344 and
53.5 mg/l to 92.8, 4.9, 20.8, 144.1, 215, 28, 230 and 7 mg/l
respectively (Table 3). Meanwhile, the turbidity decreased
from 201 to 37 NTU. It is worth to notice that the ZnO
nanoparticles were able to remove more than 95% of the
Ibuprofen, Propranolol, CODT, CODD, BOD and Na. How-
ever, 89% removal of the Ephedrine was achieved. On the
other hand, the recorded removal rate of K, Ca and Mg was
between 75% and 86% (Table 3). The removal of NH3 was
higher than that of the other nitrogen compounds namely,
NO3 and NO2. This is attributed to the conversion of NH3
by oxidation to NO2 and NO3.
The ZnO treated efﬂuent was submitted directly to the
microﬁltration semi-pilot plant for further treatment. Results
(Table 4) exhibit further decrease in the concentration of all
the studied parameters. The ﬁnal concentration of Ibuprofen,
Ephedrine and Propranolol reached 0.01, 0.10 and 0.03 mg/l
respectively. This decrease is corresponding to 99.8, 99.0 and
99.8% removal rate successively. The concentration of CODT,
CODD and BOD decreased to 79.5, 68.0 and 19.8 mg/l respec-
tively. The T.P., NO3, NO2, NH3, K, Na, Ca and Mg also
decreased to 9.0, 0.6, 1.06, 2.8, 26, 3.6, 8.0 and 0.7 mg/l succes-
sively (Table 3). In addition, turbidity decreased down to 0.6
NTU.
The overall removal of Ibuprofen, Ephedrine and Propra-
nolol via this continuous treatment system reached 99.8, 99.0
and 99.8 respectively. The corresponding overall removal rates
of COD, BOD, T.P., NO3, NO2, NH3, K, Na, Ca, Mg andPlease cite this article in press as: Hassan, S.S.M. et al., Removal of pharmaceutica
nanoparticles followed by microfiltration for safe reuse. Arabian Journal of Chemisturbidity were 99.5, 99.2, 95.5, 94, 97.6, 99.4, 91.3, 99.3, 99.4,
98.7 and 99.7% successively.3.6. Conclusions
 ZnO nanoparticles could be green synthesized by using Zn acetate
dihydrate and the extract of black tea solid waste. The average par-
ticle size was 19.5 nm as deﬁned by HR-TEM. XRD, EDAX, SEM,
and DLS. Zeta potential was used for the characterization of green
synthesized ZnO nanoparticles.
 Employing such ZnO nanoparticles at the optimum dose in a semi-
pilot plant was able to remove the studied pharmaceutical contam-
inants from urine at a rate ranged from 89% to 97%. The studied
pharmaceutical contaminants are Ibuprofen, Ephedrine and
Propranolol.
 By using ZnO nanoparticles, the pollution parameters namely
CODT, CODD and BOD were removed at a rate ranged from
95% to 97%. On the other hand, the removal rate of T.P., NO3,
NO2, NH3, K, Na, Ca, Mg and turbidity ranged between 51%
and 94%.
 By submitting the ZnO treated urine to the membrane micro-
ﬁltration (MF) in the semi-pilot plant study, the selected PACs
were successfully removed from the contaminated urine at the
range from 99.0% to 99.8%.
 By employing the designed semi-pilot plant, the overall removal
rate of the pharmaceutical compounds exceeded 99%. Meanwhile,
such treatment system was successful in improving the physical and
chemical characteristics of the contaminated urine. The overall
removal of COD, BOD, NO3, NH3, K, Na, Ca and Mg and
turbidity ranged from 91% to 99.7%. It is worth mentioning
that the removal of TP was the lowest namely 59.9% which is an
advantage of using the treated urine as a source of nutrient
elements.
 Finally, the treated urine could then safely be used for agriculture
purposes without any environmental threat.l compounds from urine via chemical coagulation by green synthesized ZnO-
try (2016), http://dx.doi.org/10.1016/j.arabjc.2016.04.009
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